Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
J Mol Cell Cardiol ; 82: 84-92, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25771143

RESUMEN

Atrial fibrillation (AF) is associated with structural remodeling in atrial myocytes. Emerging evidence suggests that statin has a protective effect on AF through cholesterol-independent mechanisms. The aim of this study is to investigate whether heme oxygenase-1 (HO-1), a potent antioxidant system, mediates the suppressive effect of statin on atrial tachycardia-induced structural remodeling. Treatment of cultured atrium-derived myocytes (HL-1 cell line) with rosuvastatin enhanced HO-1 expression/activity and attenuated tachypacing-induced oxidative stress and myofibril degradation. Heme oxygenase-1 inhibitors and small-interfering RNA for HO-1 blocked the inhibitory effect of rosuvastatin on tachypacing-stimulated changes, suggesting the crucial role of HO-1 in mediating the effect of rosuvastatin. Time-dependent experiments and loss-of-function study demonstrated that Akt/Nrf2 pathways lay to the up-stream of HO-1 in this signaling cascade. Furthermore, the involvement of Akt/Nrf2/HO-1 pathway in the antioxidant effect of rosuvastatin was documented in an ex vivo tachypacing model. The suppressive effect of statin on atrial tachypacing-induced cellular remodeling is mediated via the activation of Akt/Nrf2/HO-1 signaling, which provides a possible explanation for the protective effect of statin on AF.


Asunto(s)
Hemo-Oxigenasa 1/metabolismo , Inhibidores de Hidroximetilglutaril-CoA Reductasas/farmacología , Miocitos Cardíacos/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Proteínas Proto-Oncogénicas c-akt/metabolismo , Rosuvastatina Cálcica/farmacología , Transducción de Señal/efectos de los fármacos , Taquicardia Atrial Ectópica/metabolismo , Animales , Remodelación Atrial/efectos de los fármacos , Colágeno/metabolismo , Modelos Animales de Enfermedad , Activación Enzimática , Fibroblastos/metabolismo , Expresión Génica , Hemo-Oxigenasa 1/genética , Masculino , Estrés Oxidativo/efectos de los fármacos , Fosfatidilinositol 3-Quinasas/metabolismo , Ratas , Taquicardia Atrial Ectópica/genética , Taquicardia Atrial Ectópica/patología
2.
Europace ; 13(5): 747-54, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21297123

RESUMEN

AIMS: Rapid atrial pacing for 1 week leads to decreased expression of endocardial nitric oxide (NO)-synthase and decreased NO concentrations. We hypothesized that increasing NO bioavailability may reduce electrical remodelling induced by atrial tachycardia. METHODS AND RESULTS: We examined the effect of molsidomine, a NO donor, and N(ω)-nitro-l-arginine methylester (l-NAME), a NO-synthase inhibitor, on electrical remodelling occurring during 4 h of rapid atrial pacing in sheep. Haemodynamic and electrophysiological parameters were measured at baseline, 1 h after the start of the infusion and before the start of pacing, and 2 and 4 h after pacing. We measured the effect of molsidomine on atrial monophasic action potentials (MAPs) in non-instrumented sheep and on l-type Ca(2+) currents and intracellular Ca(2+) concentration ([Ca(2+)](i)) transients in right atrial cells, isolated from control sheep. In control sheep, rapid atrial pacing shortened the atrial effective refractory period (AERP) by 12 ± 0.18% after 4 h, an effect that was unaffected by l-NAME. Infusion of molsidomine increased AERP at baseline (+13.4 ± 1.04%) and transiently attenuated pacing-induced AERP shortening (13.6 ± 0.1% at 2 h). Molsidomine tended to increase MAP duration by 20.7 ± 13.4 ms. Incubation of isolated atrial myocytes with NO donor 3-morpholino-sydnonimine (SIN-1) increased significantly l-type Ca(2+) current and [Ca(2+)](i) transients. CONCLUSION: Infusion of molsidomine, a NO donor, delayed shortening of the action potential during short-term rapid atrial pacing, by increasing [Ca(2+)](i). Whereas the former could be protective against repetitive short episodes of atrial fibrillation, the latter might be detrimental in the long term.


Asunto(s)
Sistema de Conducción Cardíaco/efectos de los fármacos , Molsidomina/farmacología , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico/metabolismo , Taquicardia Atrial Ectópica , Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/fisiología , Animales , Presión Sanguínea/fisiología , Calcio/metabolismo , Canales de Calcio Tipo L/fisiología , Estimulación Cardíaca Artificial , Modelos Animales de Enfermedad , Femenino , Sistema de Conducción Cardíaco/fisiología , Periodo Refractario Electrofisiológico/efectos de los fármacos , Periodo Refractario Electrofisiológico/fisiología , Ovinos , Taquicardia Atrial Ectópica/tratamiento farmacológico , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatología
3.
Sci Rep ; 11(1): 11441, 2021 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-34075111

RESUMEN

In the last several years, quite a few papers on the joint question of transport, tortuosity and percolation have appeared in the literature, dealing with passage of miscellaneous liquids or electrical currents in different media. However, these methods have not been applied to the passage of action potential in heart fibrosis (HF), which is crucial for problems of heart arrhythmia, especially of atrial tachycardia and fibrillation. In this work we address the HF problem from these aspects. A cellular automaton model is used to analyze percolation and transport of a distributed-fibrosis inflicted heart-like tissue. Although based on a rather simple mathematical model, it leads to several important outcomes: (1) It is shown that, for a single wave front (as the one emanated by the heart's sinus node), the percolation of heart-like matrices is exactly similar to the forest fire case. (2) It is shown that, on the average, the shape of the transport (a question not dealt with in relation to forest fire, and deals with the delay of action potential when passing a fibrotic tissue) behaves like a Gaussian. (3) Moreover, it is shown that close to the percolation threshold the parameters of this Gaussian behave in a critical way. From the physical point of view, these three results are an important contribution to the general percolation investigation. The relevance of our results to cardiological issues, specifically to the question of reentry initiation, are discussed and it is shown that: (A) Without an ectopic source and under a mere sinus node operation, no arrhythmia is generated, and (B) A sufficiently high refractory period could prevent some reentry mechanisms, even in partially fibrotic heart tissue.


Asunto(s)
Potenciales de Acción , Fibrilación Atrial , Simulación por Computador , Modelos Cardiovasculares , Miocardio/metabolismo , Animales , Fibrilación Atrial/metabolismo , Fibrilación Atrial/fisiopatología , Fibrosis , Humanos , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatología
4.
Br J Pharmacol ; 152(7): 981-3, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17828293

RESUMEN

The common cardiac arrhythmia atrial fibrillation (AF) tends to show progression in its severity, which is associated with 'remodelling': structural and electrophysiological changes that facilitate arrhythmia induction and maintenance. In this issue of the BJP, Yeh and colleagues demonstrate for the first time, down-regulation of three types of muscarinic cholinergic receptor (mAChR) coupled K+ currents (IKM2, IKM3 and IKM4) and of M2, M3 and M4 mAChR subtype proteins, in a canine model of atrial tachycardia (AT) induced remodelling. The IKMs and their extent of AT-induced remodelling were similar in left-atrial and pulmonary vein (PV) myocytes, so remodelling of M2-M4 receptor-linked currents appears not to underlie the unique contribution of PVs to AF. Parasympathetic stimulation can increase susceptibility to AF; thus remodelling of M2-M4 receptors and K+ currents could be adaptive in AT. Further work is warranted to determine whether or not remodelling of multiple mAChRs and currents also contributes to human AF.


Asunto(s)
Fibrilación Atrial/metabolismo , Canales de Potasio de Rectificación Interna/metabolismo , Receptores Muscarínicos/metabolismo , Animales , Fibrilación Atrial/fisiopatología , Modelos Animales de Enfermedad , Regulación hacia Abajo , Humanos , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/fisiopatología
5.
Br J Pharmacol ; 152(7): 1021-32, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-17618308

RESUMEN

BACKGROUND AND PURPOSE: Both parasympathetic tone and atrial tachycardia (AT) remodelling of ion channels play important roles in atrial fibrillation (AF) pathophysiology. Different muscarinic cholinergic receptor (mAChR) subtypes (M2, M3, M4) in atrial cardiomyocytes are coupled to distinct K+-currents (called IKM2, IKM3, IKM4, respectively). Pulmonary veins (PVs) are important in AF and differential cholinergic current responses are a potential underlying mechanism. This study investigated AT-induced remodelling of mAChR subtypes and K+-currents in left-atrial (LA) and PV cardiomyocytes. EXPERIMENTAL APPROACH: Receptor expression was assayed by western blot. IKM2, IKM3 and IKM4 were recorded with whole-cell patch-clamp in LA and PV cardiomyocytes of nonpaced control dogs and dogs after 7 days of AT-pacing (400 bpm). KEY RESULTS: Current densities of IKM2, IKM3 and IKM4 were significantly reduced by AT-pacing in LA and PV cardiomyocytes. PV cardiomyocyte current-voltage relations were similar to LA for all three cholinergic currents, both in control and AT remodelling. Membrane-protein expression levels corresponding to M2, M3 and M4 subtypes were decreased significantly (by about 50%) after AT pacing. Agonist concentration-response relations for all three currents were unaffected by AT pacing. CONCLUSIONS AND IMPLICATIONS: AT downregulated all three mAChR-coupled K+-current subtypes, along with corresponding mAChR protein expression. These changes in cholinergic receptor-coupled function may play a role in AF pathophysiology. Cholinergic receptor-coupled K+-currents in PV cardiomyocytes were similar to those in LA under control and AT-pacing conditions, suggesting that differential cholinergic current properties do not explain the role of PVs in AF.


Asunto(s)
Atrios Cardíacos/metabolismo , Miocitos Cardíacos/metabolismo , Canales de Potasio de Rectificación Interna/metabolismo , Venas Pulmonares/metabolismo , Receptores Muscarínicos/metabolismo , Taquicardia Atrial Ectópica/metabolismo , Animales , Fibrilación Atrial/metabolismo , Fibrilación Atrial/fisiopatología , Western Blotting , Estimulación Cardíaca Artificial , Células Cultivadas , Modelos Animales de Enfermedad , Perros , Regulación hacia Abajo , Técnicas Electrofisiológicas Cardíacas , Potenciales Evocados , Atrios Cardíacos/patología , Miocitos Cardíacos/patología , Técnicas de Placa-Clamp , Venas Pulmonares/patología , Receptores Muscarínicos/biosíntesis , Taquicardia Atrial Ectópica/fisiopatología , Factores de Tiempo
6.
Resuscitation ; 70(3): 423-31, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-16901614

RESUMEN

BACKGROUND: Electrical cardioversion in patients with various types of supraventricular tachyarrhythmia (SVT) may induce serum cardiac markers elevation. Only a few studies have evaluated the impact of the type of shock waveform on electrical myocardial injury. The aim of our study was to compare the response of serum cardiac markers to biphasic and monophasic cardioversion for SVT. METHODS: One hundred and forty one patients with various SVTs referred for electrical cardioversion were randomised to monophasic (MP) or biphasic (BP) cardioversion. Serum levels of creatine kinase (CK), MB fraction of CK (CK-MB), myoglobin and troponin I were analysed before cardioversion and 254+/-58 min after the procedure. RESULTS: Average age of the patients was 67.9+/-11.3 years, 71 underwent BP and 70 MP cardioversion. In MP group, cumulative energy (CE)>150J was associated with significant elevation of CK and myoglobin levels after cardioversion (1.52+/-3.81 microkat/l and 187+/-433 microg/l), while CE<150J was not (-0.04+/-0.34 and 4+/-11, p<0.05). In BP group, CE>150J was associated with significant but smaller CK elevation (0.27+/-1.09 microkat/l, p<0.05) and comparable myoglobin elevation (80.7+/-21.4 microg/l, p<0.05). CE>150J was the only independent positive predictor for CK and myoglobin elevation in both groups. No significant changes in CK-MB and Troponin I levels after cardioversion were identified. CONCLUSIONS: According to our study, electrical cardioversion for SVTs is not associated with biochemical signs of myocardial injury. Application of CE>150J can be followed by CK and myoglobin elevation most likely due to skeletal muscle damage. This reaction is more pronounced in MP than in BP cardioversion.


Asunto(s)
Biomarcadores/sangre , Cardioversión Eléctrica/métodos , Taquicardia Supraventricular/sangre , Taquicardia Supraventricular/terapia , Fibrilación Atrial/sangre , Fibrilación Atrial/metabolismo , Fibrilación Atrial/terapia , Aleteo Atrial/sangre , Aleteo Atrial/metabolismo , Aleteo Atrial/terapia , Humanos , Taquicardia Atrial Ectópica/sangre , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/terapia , Taquicardia Supraventricular/metabolismo
7.
Pharmacotherapy ; 24(7): 879-95, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15303452

RESUMEN

Atrial tachyarrhythmias, including atrial fibrillation and flutter, occur frequently. Magnesium has been studied in the early conversion and prevention of atrial tachyarrhythmias, as well as in prevention of atrial tachyarrhythmias after coronary artery bypass graft surgery. Early conversion of atrial tachyarrhythmias and control of heart rate may be greater with magnesium than with common antiarrhythmic agents. Magnesium appears to be less useful for preventing recurrent atrial tachyarrhythmias; however, discrepancies in study methodologies make interpretation of results difficult. The use of magnesium for prevention of postoperative atrial arrhythmias has produced conflicting results, likely due to differences in study design. From the limited data available, magnesium appears to have some inherent antiarrhythmic properties. Certain patient populations may derive benefit from magnesium for the treatment of atrial tachyarrhythmias. However, further study is necessary to define the role of magnesium clearly for the treatment or prevention of atrial tachyarrhythmias.


Asunto(s)
Magnesio/uso terapéutico , Taquicardia Atrial Ectópica/tratamiento farmacológico , Humanos , Magnesio/metabolismo , Deficiencia de Magnesio/tratamiento farmacológico , Deficiencia de Magnesio/metabolismo , Taquicardia Atrial Ectópica/metabolismo
9.
Am J Physiol Heart Circ Physiol ; 295(2): H691-8, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18539751

RESUMEN

The purpose of the present study was to determine whether thoracic veins may act as ectopic pacemakers and whether nodelike cells and rich sympathetic innervation are present at the ectopic sites. We used a 1,792-electrode mapping system with 1-mm resolution to map ectopic atrial arrhythmias in eight normal dogs during in vivo right and left stellate ganglia (SG) stimulation before and after sinus node crushing. SG stimulation triggered significant elevations of transcardiac norepinephrine levels, sinus tachycardia in all dogs, and atrial tachycardia in two of eight dogs. Sinus node crushing resulted in a slow junctional rhythm (51 +/- 6 beats/min). Subsequent SG stimulation induced 20 episodes of ectopic beats in seven dogs and seven episodes of pulmonary vein tachycardia in three dogs (cycle length 273 +/- 35 ms, duration 16 +/- 4 s). The ectopic beats arose from the pulmonary vein (n = 11), right atrium (n = 5), left atrium (n = 2), and the vein of Marshall (n = 2). There was no difference in arrhythmogenic effects of left vs. right SG stimulation (13/29 vs. 16/29 episodes, P = nonsignificant). There was a greater density of periodic acid Schiff-positive cells (P < 0.05) and sympathetic nerves (P < 0.05) at the ectopic sites compared with other nonectopic atrial sites. We conclude that, in the absence of a sinus node, thoracic veins may function as subsidiary pacemakers under heightened sympathetic tone, becoming the dominant sites of initiation of focal atrial arrhythmias that arise from sites with abundant sympathetic nerves and periodic acid Schiff-positive cells.


Asunto(s)
Relojes Biológicos , Estimulación Eléctrica , Ganglio Estrellado/fisiopatología , Fibras Simpáticas Posganglionares/fisiopatología , Taquicardia Atrial Ectópica/fisiopatología , Taquicardia Sinusal/fisiopatología , Tórax/irrigación sanguínea , Animales , Mapeo del Potencial de Superficie Corporal , Perros , Epinefrina/sangre , Interpretación de Imagen Asistida por Computador , Norepinefrina/sangre , Reacción del Ácido Peryódico de Schiff , Venas Pulmonares/inervación , Venas Pulmonares/fisiopatología , Nodo Sinoatrial/fisiopatología , Fibras Simpáticas Posganglionares/metabolismo , Taquicardia Atrial Ectópica/metabolismo , Taquicardia Atrial Ectópica/patología , Taquicardia Sinusal/metabolismo , Taquicardia Sinusal/patología , Factores de Tiempo , Venas/inervación , Venas/fisiopatología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA